Whether you’re trying to lose weight, gain weight, or just stay healthy, the New Year always brings a new set of goals and resolutions. While this change in lifestyle can often feel daunting, achieving goals does not have to be a solo mission.
“Let friends, family members and co-workers know what your goal is and what you are trying to do,” says Nancy Campbell, MS, exercise physiologist with Dana-Farber Cancer Institute. “Having these people around can give you the support you need to reach that goal.”
As you work out healthy goals for 2014, consider these five tips from Campbell and Dana-Farber nutritionist Stacy Kennedy, MPH, RD:
Care for adults, General interest, Health and wellness
cancer care, cancer nutrition, health tips, healthy eating, healthy living, Nancy Campbell, new year's 2014, new year's resolutions, Stacy Kennedy
Experts with the U.S. Preventive Services Task Force (USPSTF) have recommended that current smokers and former-smokers who recently quit should undergo an annual low-dose CT scan to screen for lung cancer.
As 2013 comes to a close, we’re looking back at some of our favorite Insight posts from the last year. From inspiring patient stories to important research, here is our top 10 list:
Approximately 173,000 people in the United States are living with Hodgkin lymphoma, or are in remission. Less common than non-Hodgkin lymphoma, Hodgkin lymphoma (sometimes referred to as Hodgkin’s lymphoma) is a malignancy of B lymphocytes, an important cell in the immune system. This malignant B cell is known as the Reed-Sternberg cell.
Arnold Freedman, MD, clinical director of the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program, answers some questions about the disease:
Lymphoma: How do we treat it? Where are future therapies headed?
Ann LaCasce, MD
On Wednesday, Dec. 18, Ann LaCasce, MD, of the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program will answer your questions about lymphoma care in a live video webchat. The 45-minute chat starts at 1 p.m. EST and will air live on Dana-Farber’s YouTube page.
LaCasce will discuss current treatment options as well as future therapies for lymphoma.
If you have a question for Dr. LaCasce, email email@example.com. You can also submit questions by sending us a Tweet @DanaFarber using the hashtag #DFCIWebchat.
Bookmark the webchat video page and tune in live on Dec. 18 at 1 p.m. EST. You can also add the event to your calendar or RSVP on Facebook.
By Maggie Loucks, NP-C
When I was diagnosed with breast cancer at age 28, during my last semester of graduate school, I remember thinking that this had to mean something. I needed to turn an unfortunate situation into something positive, so I decided to pursue oncology nursing where I felt I could make a difference. Read more
When Tara Shuman was diagnosed with breast cancer in August 2012, blogging was not the first thing that came to mind.
“I put together an email to my friends and family to tell them about my diagnosis, and I realized when writing the email that it was very therapeutic,” Shuman says.
By Julie Salinger, LICSW
The holiday season is full of cheer, but it can also be stressful, especially for cancer patients and their family caregivers. In addition to the extra time spent on shopping, cooking, and socializing, family interactions may bring complex dynamics, old grievances, and varying expectations to the forefront. The pressure to be “festive” can make even the healthiest person weary.
Here are some tips for patients and their families for an enjoyable holiday season. Read more
Stem cell transplantation (sometimes called bone marrow transplants) is a treatment for certain forms of cancer, such as leukemia, lymphoma, and multiple myeloma, as well as other diseases. But before a patient can receive a transplant, stem cells must be collected from a donor (an allogeneic donation) or from the patient (an autologous transplant). Read more
Current lymphoma therapies are a far cry from the mustard gas used more than 50 years ago. More treatment options, including ones that may be more effective and less toxic, are being studied in ongoing clinical trials.
“Clinical trials really are the future of lymphoma treatment,” says Ann LaCasce, MD, a medical oncologist in the Adult Lymphoma Program at Dana-Farber/Brigham and Women’s Cancer Center.